2viw
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | == | + | ==Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator== |
<StructureSection load='2viw' size='340' side='right' caption='[[2viw]], [[Resolution|resolution]] 2.05Å' scene=''> | <StructureSection load='2viw' size='340' side='right' caption='[[2viw]], [[Resolution|resolution]] 2.05Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| Line 32: | Line 32: | ||
</div> | </div> | ||
<div class="pdbe-citations 2viw" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 2viw" style="background-color:#fffaf0;"></div> | ||
| - | |||
| - | ==See Also== | ||
| - | *[[Urokinase|Urokinase]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 47: | Line 44: | ||
[[Category: Frederickson, M]] | [[Category: Frederickson, M]] | ||
[[Category: Matthews, J E]] | [[Category: Matthews, J E]] | ||
| - | [[Category: | + | [[Category: McMenamin, R]] |
[[Category: Smith, D]] | [[Category: Smith, D]] | ||
[[Category: Vinkovic, M]] | [[Category: Vinkovic, M]] | ||
| Line 58: | Line 55: | ||
[[Category: Inhibitor]] | [[Category: Inhibitor]] | ||
[[Category: Kringle]] | [[Category: Kringle]] | ||
| + | [[Category: Pharmaceutical]] | ||
[[Category: Phosphorylation]] | [[Category: Phosphorylation]] | ||
[[Category: Plasminogen activation]] | [[Category: Plasminogen activation]] | ||
| + | [[Category: Polymorphism]] | ||
[[Category: Protease]] | [[Category: Protease]] | ||
[[Category: Secreted]] | [[Category: Secreted]] | ||
Revision as of 07:25, 16 November 2017
Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator
| |||||||||||
Categories: Human | U-plasminogen activator | Callaghan, O | Chessari, G | Congreve, M | Cowan, S R | Frederickson, M | Matthews, J E | McMenamin, R | Smith, D | Vinkovic, M | Wallis, N G | Blood coagulation | Egf-like domain | Fibrinolysis | Glycoprotein | Hydrolase | Inhibitor | Kringle | Pharmaceutical | Phosphorylation | Plasminogen activation | Polymorphism | Protease | Secreted | Serine protease | Urokinase-type plasminogen activator | Zymogen
